Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Disease Progression and MGMT[original query] |
|---|
| Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2015 Sep 22 (9): 1425-9. Kong Doo-Sik, Kim Hong Rye, Choi Yoon-Ra, Seol Ho Jun, Lee Jung-Il, Nam Do-Hy |
| Karnofsky Performance Scale and Neurological Assessment of Neuro-Oncology Scale as Early Predictor in Glioma. Asian Pacific journal of cancer prevention : APJCP 2020 11 21 (11): 3387-3392. Gunawan Pricilla Yani, Islam Andi Asadul, July Julius, Patellongi Ilhamjaya, Nasrum Muhammad, Aninditha Tia |
| ADD3 Deletion in Glioblastoma Predicts Disease Status and Survival. Frontiers in oncology 2021 12 11 717793. Kiang Karrie Mei-Yee, Sun Stella, Leung Gilberto Ka-K |
| Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients. ESMO open 2023 5 8 (3): 101570. S Giunco, M Padovan, C Angelini, F Cavallin, G Cerretti, M Morello, M Caccese, B Rizzo, D d'Avella, A D Puppa, F Chioffi, P De Bonis, V Zagonel, A De Rossi, G Lombar |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: